Trial
NCT01564277
Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Roswell Park Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Intervention
rasburicase
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-09